WuXi XDC and LigaChem Optimize ADC Development through Expanded Partnership WuXi XDC and LigaChem Biosciences have enhanced their collaboration with a new MOU to accelerate the development of next-gen ADC therapies, improving treatment options for cancer patients.

WuXi XDC and LigaChem Optimize ADC Development through Expanded Partnership #China #Shanghai #ADC_Development #WuXi_XDC #LigaChem